The intraurethral catheter--three years of experience.
Ninety-four patients with benign prostatic hyperplasia who had anesthetic contraindications to surgery were treated by insertion of 130 intraurethral catheters (IUC). Of the 130 IUCs inserted, 80.8% were successful and in 19.2% the IUC had to be removed earlier than intended: improper placement, displacement of the stent and residual urine were the main reasons for failure. All patients with a successfully inserted IUC were continent. Fifty-three IUCs were left for 1-6 months and 52 stents remained in place for over 6 up to 19 months. Bacteriuria was found in 13% of the patients with IUCs, but only 2.4% of the patients had clinical urinary tract infection. The IUC may be used as an alternative to surgery in high risk patients and as an alternative to an indwelling catheter.
Nissenkorn
I
I
Department of Urology, Meir General Hospital, Kfar Saba, Israel.
D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014521:Urethra; D014546:Urinary Catheterization